Novo Nordisk | NVO - Ebitda





Ebitda Zmiana Data
ANI Pharmaceuticals USD 71.6M 6.69M 2026-06
Aurora Cannabis CAD 3.7M 14.78M 2026-03
Bausch Health Companies USD 1.08B 238M 2026-06
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Canopy Growth CAD -137M 134.13M 2026-03
Corcept Therapeutics USD -49M 53.2M 2026-03
Drreddys Laboratories INR 8.63B 12.96B 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Merck USD -1.54B 7.84B 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Novo Nordisk DKK 37.36B 2.64B 2026-06
Novo Nordisk DKK 37.36B 31.84B 2026-06
Pacira USD 48.67M 8.43M 2026-06
Perrigo USD 141.6M 1.34B 2026-03
Phibro Animal Health USD 68.1M 6.2M 2025-12
Prestige Brands USD 61.24M 23.31M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Supernus Pharmaceuticals USD 31.6M 2.37M 2026-06
Zoetis USD 939M 0 2026-03